Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

Fig. 4

Overall survival curve in all patients. a Overall survival curve in all patients. b The patients with better response either for IFN-alpha, IFN-alpha plus sorafenib, or axitinib showed longer survival than those with poorer response. c This survival curve is based on the median values of preoperative serum sIL-2R level in all cases. The cases were divided into two groups at this level - high and low value. P value was analyzed by log-rank test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us